AGI-1067: Final Phase IIb data

Final data from the placebo-controlled, Canadian Phase IIb CART-2 trial in 232 evaluable

Read the full 130 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE